CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The RITA-MI project aims to develop a new therapy for patients experiencing acute myocardial infarction by targeting the immune response of B lymphocytes. Utilizing the drug rituximab, the project seeks to reduce heart damage and improve recovery outcomes through a single infusion treatment.
Cardiovascular diseases (CVD) represent a major cause of morbidity and mortality.
The best current therapy reduces CV risk by only 25-30% and remains ineffective in reducing the excess risk associated with several co-morbidities.
Therefore, there is considerable need for new therapies to limit the burden of CVD.
Based on a current ERC Starting Grant project, the applicant’s group proposed and validated the concept that mature B lymphocytes are instrumental in the orchestration of the inflammator…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
PAPWORTH HOSPITAL NHS FOUNDATION TRUST
United Kingdom, Cambridge
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
